We are live on ! Find out more
NUVB icon

Nuvation Bio

98 hedge funds and large institutions have $1.5B invested in Nuvation Bio in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 22

58% more call options, than puts

Call options by funds: $396K | Put options by funds: $250K

10% more capital invested

Capital invested by funds: $1.36B → $1.5B (+$139M)

1.48% more ownership

Funds ownership: 67.99%69.47% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

1% less funds holding

Funds holding: 9998 (-1)

Holders
98
Holders Change
-1
Holders Change %
-1.01%
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
15
Increased
38
Reduced
22
Closed
16
Calls
$396K
Puts
$250K
Net Calls
+$146K
Net Calls Change
+$1.37M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
26
Clearline Capital
New York
$3.84M +$1.5M +165,137 +75%
Millennium Management
27
Millennium Management
New York
$3.71M +$3.39M +373,471 New
CAC
28
Cowen and Company
New York
$3.57M
CS
29
Candriam SCA
Luxembourg
$2.85M +$2.6M +287,099 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.82M +$1.22M +134,797 +91%
Swiss National Bank
31
Swiss National Bank
Switzerland
$2.63M +$17.2K +1,900 +0.7%
6CM
32
683 Capital Management
New York
$2.45M
RSCM
33
Rock Springs Capital Management
Maryland
$2.35M -$44.2K -4,876 -2%
Victory Capital Management
34
Victory Capital Management
Texas
$2M -$14.3K -1,580 -0.8%
CAM
35
Cresset Asset Management
Illinois
$1.86M
PVI
36
Pura Vida Investments
New York
$1.77M +$1.62M +178,403 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.65M -$31K -3,424 -2%
IP
38
Intellectus Partners
California
$1.53M +$308K +33,995 +28%
Point72 Asset Management
39
Point72 Asset Management
Connecticut
$1.51M +$1.38M +152,300 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$1.33M +$771K +85,040 +174%
Wells Fargo
41
Wells Fargo
California
$1.01M +$436K +48,114 +90%
UBS AM
42
UBS AM
Illinois
$885K
CS
43
Credit Suisse
Switzerland
$858K +$1.81K +200 +0.2%
Morgan Stanley
44
Morgan Stanley
New York
$764K +$221K +24,419 +47%
Goldman Sachs
45
Goldman Sachs
New York
$545K -$966K -106,556 -66%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$521K +$161K +17,730 +51%
JP Morgan Chase
47
JP Morgan Chase
New York
$516K -$75K -8,270 -14%
Renaissance Technologies
48
Renaissance Technologies
New York
$501K -$3.77M -416,400 -89%
AllianceBernstein
49
AllianceBernstein
Tennessee
$498K -$37.2K -4,100 -8%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$459K +$419K +46,200 New

NUVB Hedge Fund Activity: Q3 2021 in Review

98 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q3 2021, worth a combined $1.5B — up 10% from $1.36B a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of NUVB and 15 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 38 added.

The largest buyer was BlackRock, adding an estimated $19.8M. The largest seller was Franklin Resources, exiting entirely with an estimated $7.45M sold.

  • 98 institutional investors held Nuvation Bio (NUVB) as of Q3 2021, down from 99 in Q2 2021.
  • Funds reported $1.5B of Nuvation Bio stock for Q3 2021, up 10% quarter-over-quarter.
  • 15 funds opened new Nuvation Bio positions in Q3 2021 and 16 closed out, a net change of -1 holder.
  • The largest Nuvation Bio buyer in Q3 2021 was BlackRock, an estimated $19.8M added.
  • The largest Nuvation Bio seller in Q3 2021 was Franklin Resources, an estimated $7.45M sold.

Based on aggregated 13F filings for Q3 2021.